Merck revenue falls after dramatic drop in sales of Covid antiviral treatment
April 27, 2023 at 06:41 AM EDT
Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for Q1 2023 beat Wall Street's expectations.
Photography by Christophe Tomatis